<DOC>
	<DOCNO>NCT02755870</DOCNO>
	<brief_summary>This Phase 1 , First-Time-In-Humans , randomize , placebo-controlled , double-blind , escalate single- multiple-dose study evaluate safety , tolerability , pharmacokinetics CNM-Au8 healthy male female volunteer . There 2 phase study : single ascend dose ( SAD ) phase multiple ascend dose ( MAD ) phase . The SAD Phase conduct first follow MAD phase study .</brief_summary>
	<brief_title>A Phase I SAD MAD Clinical Trial CNM-Au8 Healthy Male Female Volunteers</brief_title>
	<detailed_description>SAD Phase : A total 8 subject randomly assign 3:1 ratio receive single dose either CNM-Au8 ( n=6 ) placebo ( n=2 ) initial dose level 15 mg CNM-Au8 . Additional cohorts 8 subject enrol investigate escalate single dos CNM-Au8 30 , 60 , 90 mg . Cohorts balance sex 2/3rd subject one sex . MAD Phase : A total 12 subject randomly assign 3:1 ratio receive multiple dose either CNM-Au8 ( n=9 ) placebo ( n=3 ) daily 21 day initial dose level 15 mg CNM-Au8 . Additional cohorts 12 subject enrol investigate escalate multiple dos CNM-Au8 30 , 60 , 90 mg CNM Au8 administer daily 21 day . Cohorts balance sex 2/3rd subject one sex .</detailed_description>
	<criteria>An Institutional Review Board ( IRB ) approve informed consent sign date prior studyrelated activity . Females nonpregnant , nonlactating , postmenopausal All laboratory value screen fall within normal range evaluate clinically significant Has consume agree abstain taking dietary supplement nonprescription drug Has consume agree abstain taking prescription drug Has consume alcoholcontaining beverage Has consume grapefruit grapefruit juice Has use tobacco nicotinecontaining product Has ability understand requirement study willing comply study procedure . Has history illicit drug abuse Has clinically significant medical psychiatric history Has donate plasma excessive blood loss Prior participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>